<DOC>
	<DOCNO>NCT00694122</DOCNO>
	<brief_summary>1 . To investigate effect insulin glargine ( Lantusâ„¢ ) v NPH insulin regard glycemic control early AM ( dawn phenomenon ) individual type 1 diabetes . 2 . To measure hormone implicate pathogenesis dawn phenomenon individual type 1 diabetes .</brief_summary>
	<brief_title>Comparison Lantus Neutral Protamine Hagedorn ( NPH ) Insulin Dawn Phenomenon</brief_title>
	<detailed_description>Title : COMPARISON LANTUS NPH INSULIN IN THE DAWN PHENOMENON I . Background Significance Diabetes mellitus affect great 6 % population , type 2 prevalent type 1 . For individual type 1 diabetes , challenge replicate insulin secretion healthy pancreas maintain blood glucose close non-diabetic range possible . Insulin regimes use insulin varied activity profile ( multiple daily injection MDI ) continuous subcutaneous insulin infusion ( CSII ) somewhat successful `` mimicking '' normal pancreatic function ( 1 , 2 ) . For individual type 1 diabetes , benefit near-normal , long-term glycemic control delay development slow progression long-term complication demonstrate Diabetes Control Complications Trial ( 3 ) . Intensive insulin therapy achieve near-normal glycemic control limit three-fold increase episode hypoglycemia ( 3 , 4 ) . Insulin analogs provide stable physiologic insulin level lead development newer MDI regimes ( 5 ) . Glargine ( Lantus ) long-acting recombinant human insulin analog demonstrate provide continuous , smooth supply insulin pronounce peak 24-hour period ( 6 ) . An increase blood glucose type 1 type 2 diabetic , increase insulin secretion maintain normoglycemia non-diabetics , document several study 1980s ( 15-17 ) . This physiological requirement insulin delivery ( secretion ) early ( 4:00-6:00 AM ) hour term `` dawn phenomenon '' . The mechanism dawn phenomenon think overnight increase growth hormone section , rather diurnal glucocorticoid ( 16 , 18 , 19 ) . Most intensive treatment regimens 1980-90 's , MDI CSII , design provide insulin 4:00-7:00 AM period cope dawn phenomenon achieve glargine ( 20-21 ) . Continuous monitor blood glucose reveal individual treat CSII significantly good glycemic control glargine treat individual ( 22 ) . Whether dawn phenomenon , increase area curve blood glucose level dawn period limit effectiveness regimen glargine crucial importance .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<criteria>Written inform consent obtain prior perform screen evaluation . Male female , 18 yr old . Diagnosis type 1 diabetes make 5 year prior screen visit . A1C &gt; 6.0 % 9.0 % screen visit . Body Mass Index ( BMI ) 35 kg/m2 screen visit . Documented undetectable CPeptide Ability follow instruction Continuous Glucose Monitoring System ( CGMS ) . Multiple daily injection participant least 3 injection per day . May treat NPH glargine . Pregnant lactating female , female plan become pregnant study use acceptable method contraception . Females childbearing potential must negative pregnancy test Visit 3 Visit 5 . Females become pregnant study discontinue . Type 2 diabetes . Two severe hypoglycemic episode ( require assistance ) within six month Screening . Drugs known affect glycemia ( eg . steroid , beta blocker ) condition likely require steroid therapy cause metabolic instability next 6 month . History allergy intolerance NPH glargine . History hypoglycemia unawareness i.e . warn symptom accompany low ( &lt; 50 mg/dl ) blood glucose level . Unable and/or unlikely comprehend and/or follow study protocol ( include self blood glucose monitoring , CGMS ) . Currently use insulin pump . Pituitary disorder ( Acromegaly , Cushing 's , Hypothyroidism etc . ) tumor . Two severe hypoglycemic episode ( require assistance ) within six month Screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>glucose</keyword>
	<keyword>cortisol</keyword>
	<keyword>growth hormone</keyword>
	<keyword>glucagon</keyword>
	<keyword>insulin</keyword>
</DOC>